198 related articles for article (PubMed ID: 38310103)
1. ANKRD1 is a mesenchymal-specific driver of cancer-associated fibroblast activation bridging androgen receptor loss to AP-1 activation.
Mazzeo L; Ghosh S; Di Cicco E; Isma J; Tavernari D; Samarkina A; Ostano P; Youssef MK; Simon C; Dotto GP
Nat Commun; 2024 Feb; 15(1):1038. PubMed ID: 38310103
[TBL] [Abstract][Full Text] [Related]
2. Androgen receptor functions as transcriptional repressor of cancer-associated fibroblast activation.
Clocchiatti A; Ghosh S; Procopio MG; Mazzeo L; Bordignon P; Ostano P; Goruppi S; Bottoni G; Katarkar A; Levesque M; Kölblinger P; Dummer R; Neel V; Özdemir BC; Dotto GP
J Clin Invest; 2018 Dec; 128(12):5531-5548. PubMed ID: 30395538
[TBL] [Abstract][Full Text] [Related]
3. ANKRD1 acts as a transcriptional repressor of MMP13 via the AP-1 site.
Almodóvar-García K; Kwon M; Samaras SE; Davidson JM
Mol Cell Biol; 2014 Apr; 34(8):1500-11. PubMed ID: 24515436
[TBL] [Abstract][Full Text] [Related]
4. Ankrd1 is a transcriptional repressor for the androgen receptor that is downregulated by testosterone.
Wu Y; Ruggiero CL; Bauman WA; Cardozo C
Biochem Biophys Res Commun; 2013 Aug; 437(3):355-60. PubMed ID: 23811403
[TBL] [Abstract][Full Text] [Related]
5. Nuclear lamin A/C phosphorylation by loss of Androgen Receptor is a global determinant of cancer-associated fibroblast activation.
Ghosh S; Isma J; Mazzeo L; Toniolo A; Simon C; Dotto GP
bioRxiv; 2023 Jun; ():. PubMed ID: 37425957
[TBL] [Abstract][Full Text] [Related]
6. Loss of androgen receptor signaling in prostate cancer-associated fibroblasts (CAFs) promotes CCL2- and CXCL8-mediated cancer cell migration.
Cioni B; Nevedomskaya E; Melis MHM; van Burgsteden J; Stelloo S; Hodel E; Spinozzi D; de Jong J; van der Poel H; de Boer JP; Wessels LFA; Zwart W; Bergman AM
Mol Oncol; 2018 Aug; 12(8):1308-1323. PubMed ID: 29808619
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor in cancer-associated fibroblasts influences stemness in cancer cells.
Liao CP; Chen LY; Luethy A; Kim Y; Kani K; MacLeod AR; Gross ME
Endocr Relat Cancer; 2017 Apr; 24(4):157-170. PubMed ID: 28264911
[TBL] [Abstract][Full Text] [Related]
8. Targeting nuclear receptors in cancer-associated fibroblasts as concurrent therapy to inhibit development of chemoresistant tumors.
Chan JSK; Sng MK; Teo ZQ; Chong HC; Twang JS; Tan NS
Oncogene; 2018 Jan; 37(2):160-173. PubMed ID: 28892046
[TBL] [Abstract][Full Text] [Related]
9. Cancer-associated fibroblasts secrete hypoxia-induced serglycin to promote head and neck squamous cell carcinoma tumor cell growth in vitro and in vivo by activating the Wnt/β-catenin pathway.
Xie J; Qi X; Wang Y; Yin X; Xu W; Han S; Cai Y; Han W
Cell Oncol (Dordr); 2021 Jun; 44(3):661-671. PubMed ID: 33651283
[TBL] [Abstract][Full Text] [Related]
10. The ULK3 Kinase Is Critical for Convergent Control of Cancer-Associated Fibroblast Activation by CSL and GLI.
Goruppi S; Procopio MG; Jo S; Clocchiatti A; Neel V; Dotto GP
Cell Rep; 2017 Sep; 20(10):2468-2479. PubMed ID: 28877478
[TBL] [Abstract][Full Text] [Related]
11. LMO2 upregulation due to AR deactivation in cancer-associated fibroblasts induces non-cell-autonomous growth of prostate cancer after androgen deprivation.
Chen L; Wang YY; Li D; Wang C; Wang SY; Shao SH; Zhu ZY; Zhao J; Zhang Y; Ruan Y; Han BM; Xia SJ; Jiang CY; Zhao FJ
Cancer Lett; 2021 Apr; 503():138-150. PubMed ID: 33503448
[TBL] [Abstract][Full Text] [Related]
12. Global deletion of Ankrd1 results in a wound-healing phenotype associated with dermal fibroblast dysfunction.
Samaras SE; Almodóvar-García K; Wu N; Yu F; Davidson JM
Am J Pathol; 2015 Jan; 185(1):96-109. PubMed ID: 25452119
[TBL] [Abstract][Full Text] [Related]
13. Fibroblast subsets in non-small cell lung cancer: Associations with survival, mutations, and immune features.
Pellinen T; Paavolainen L; Martín-Bernabé A; Papatella Araujo R; Strell C; Mezheyeuski A; Backman M; La Fleur L; Brück O; Sjölund J; Holmberg E; Välimäki K; Brunnström H; Botling J; Moreno-Ruiz P; Kallioniemi O; Micke P; Östman A
J Natl Cancer Inst; 2023 Jan; 115(1):71-82. PubMed ID: 36083003
[TBL] [Abstract][Full Text] [Related]
14. Upregulation of Nox4 induces a pro-survival Nrf2 response in cancer-associated fibroblasts that promotes tumorigenesis and metastasis, in part via Birc5 induction.
Mir S; Golden BDO; Griess BJ; Vengoji R; Tom E; Kosmacek EA; Oberley-Deegan RE; Talmon GA; Band V; Teoh-Fitzgerald ML
Breast Cancer Res; 2022 Jul; 24(1):48. PubMed ID: 35836253
[TBL] [Abstract][Full Text] [Related]
15. Dualism of FGF and TGF-β Signaling in Heterogeneous Cancer-Associated Fibroblast Activation with ETV1 as a Critical Determinant.
Bordignon P; Bottoni G; Xu X; Popescu AS; Truan Z; Guenova E; Kofler L; Jafari P; Ostano P; Röcken M; Neel V; Dotto GP
Cell Rep; 2019 Aug; 28(9):2358-2372.e6. PubMed ID: 31461652
[TBL] [Abstract][Full Text] [Related]
16. Insights into Fibroblast Plasticity: Cellular Communication Network 2 Is Required for Activation of Cancer-Associated Fibroblasts in a Murine Model of Melanoma.
Tsang M; Quesnel K; Vincent K; Hutchenreuther J; Postovit LM; Leask A
Am J Pathol; 2020 Jan; 190(1):206-221. PubMed ID: 31610176
[TBL] [Abstract][Full Text] [Related]
17. A novel role for cardiac ankyrin repeat protein Ankrd1/CARP as a co-activator of the p53 tumor suppressor protein.
Kojic S; Nestorovic A; Rakicevic L; Belgrano A; Stankovic M; Divac A; Faulkner G
Arch Biochem Biophys; 2010 Oct; 502(1):60-7. PubMed ID: 20599664
[TBL] [Abstract][Full Text] [Related]
18. Transcription factors in fibroblast plasticity and CAF heterogeneity.
Melchionna R; Trono P; Di Carlo A; Di Modugno F; Nisticò P
J Exp Clin Cancer Res; 2023 Dec; 42(1):347. PubMed ID: 38124183
[TBL] [Abstract][Full Text] [Related]
19. Cell-lineage specificity and role of AP-1 in the prostate fibroblast androgen receptor cistrome.
Leach DA; Panagopoulos V; Nash C; Bevan C; Thomson AA; Selth LA; Buchanan G
Mol Cell Endocrinol; 2017 Jan; 439():261-272. PubMed ID: 27634452
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of FGFR2
Qiu H; Zhang X; Qi J; Zhang J; Tong Y; Li L; Fu L; Qin YR; Guan X; Zhang L
J Exp Clin Cancer Res; 2022 Aug; 41(1):240. PubMed ID: 35941662
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
